Literature DB >> 1444724

Anxiogenic effects of caffeine in patients with anxiety disorders.

M Bruce1, N Scott, P Shine, M Lader.   

Abstract

The effects on measures of anxiety from two doses of oral caffeine (250 and 500 mg) and placebo were compared in 12 patients with generalized anxiety disorder (GAD), 12 patients with panic disorder, and 12 normal subjects. Caffeine produced significantly less decrease in electroencephalographic alpha wave activity, greater decrease in N1-P2 auditory evoked potential amplitude, and greater increased in skin conductance level, systolic and diastolic blood pressure, critical fusion flicker frequency, and self-ratings of anxiety and sweating in patients with GAD than in normal patients. Patients with panic disorder showed different reactivity than normal patients did with respect to electroencephalographic alpha waves, N2 latency, N2-P2 auditory evoked potential amplitude, and physical tiredness but were less reactive than patients with GAD on several variables. It is concluded that patients with GAD are abnormally sensitive to caffeine and that the data support the view that panic disorder is a separable disorder from GAD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444724     DOI: 10.1001/archpsyc.1992.01820110031004

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  16 in total

1.  Heavy coffee drinking and the risk of suicide.

Authors:  A Tanskanen; J Tuomilehto; H Viinamäki; E Vartiainen; J Lehtonen; P Puska
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

Review 2.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

3.  Energy drinks: psychological effects and impact on well-being and quality of life-a literature review.

Authors:  Waguih William Ishak; Chio Ugochukwu; Kara Bagot; David Khalili; Christine Zaky
Journal:  Innov Clin Neurosci       Date:  2012-01

4.  ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Authors:  Katharina Domschke; Agnieszka Gajewska; Bernward Winter; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Evelyn Glotzbach; Annette Conzelmann; Andrea Dlugos; Manfred Fobker; Christian Jacob; Volker Arolt; Andreas Reif; Paul Pauli; Peter Zwanzger; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

5.  Risk for suicidal behaviors associated with alcohol and energy drink use in the US Army.

Authors:  Holly B Herberman Mash; Carol S Fullerton; Holly J Ramsawh; Tsz Hin H Ng; Leming Wang; Ronald C Kessler; Murray B Stein; Robert J Ursano
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-05-06       Impact factor: 4.328

6.  Anxiety Disorders in Neurologic Illness.

Authors:  Robert D. Davies; Sherri L. Gabbert; Paula D. Riggs
Journal:  Curr Treat Options Neurol       Date:  2001-07       Impact factor: 3.598

Review 7.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 8.  Modulation of neuroimmunity by adenosine and its receptors: metabolism to mental illness.

Authors:  Gabriel S Chiu; Gregory G Freund
Journal:  Metabolism       Date:  2014-09-26       Impact factor: 8.694

9.  Common psychiatric disorders and caffeine use, tolerance, and withdrawal: an examination of shared genetic and environmental effects.

Authors:  Jocilyn E Bergin; Kenneth S Kendler
Journal:  Twin Res Hum Genet       Date:  2012-08       Impact factor: 1.587

10.  Pharmacokinetic and pharmacodynamic responses to caffeine in poor and normal sleepers.

Authors:  P Tiffin; H Ashton; R Marsh; F Kamali
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.